ClinicalTrials.gg
CompletedNCT07764406RCT NICE ACOGUpdated Aug 13, 2026

Effect Of Amniotomy In Early Labour On Duration Of Labour

An interventional study of Amniotomy (intentional rupture of amniotic sac during labour) in Labour, sponsored by Indus Hospital and Health Network. Completed at 1 site in Pakistan. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-08-13.

Sponsored by Indus Hospital and Health Network · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Oct 2025, registered Jul 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

The goal of this clinical trial is to learn if intentional rupturing of amniotic sac in early labour works to shorten the duration of labour.

The main question it aims to answer is

. Does the intentional rupture of amniotic sac in early labour lowers the duration of labour in primigravida at term as compared to expectant management.

The researchers will compare mean duration of labor in intentional rupture of amniotic sac in early labour group to expectant management untill spontaneous rupture of amniotic sac in primigravida at term pregnancy.

The participants will be randomly assigned to group A and B through lottery method using sealed opaque envelopes.

In group A, amniotomy at 3cm will be done using aseptic measurements with the help of forcep. while in group B, membranes will be left intact. A partograph will be maintained in all patients throughout labor. Duration of each stage of labour will be monitored as per operational definition by the nurse not aware of treatment given. Fetal and maternal monitoring will be done half hourly till delivery of infant. Cesarean-section will be done in non-reactive CTG patients. In case of any of the adverse events related to intervention like placental abruption and cord prolapse [that is less likely as the subjects are primigravida patients in which head is mostly already engaged before onset of labour], and presence of meconium upon ARM that is not related to intervention individualized care will be provided like continuous electronic fetal monitoring and emergency caserean section will be kept in hand. If any adverse event occur related to intervention it will be reported to IRB within 24hours. All the patients will be kept under observation for 24 hours after delivery. All the data will be recorded on proforma

Read the detailed description

Effect of Amniotomy in Early Labour on Duration of Labour in Primigravida at Term Pregnancy: A Randomized Controlled Trial.

Introduction Labor is a physiological but painful experience for women. It is a dynamic and ongoing process that culminates with the delivery of a healthy baby, followed by the ejection of the placenta and membranes.After active labor has begun, the membranes burst, which is known as spontaneous membrane rupture.Amniotomy is the artificial breach of the amniotic membrane with the primary goal of accelerating contraction and shortening the duration of labor.Studies have shown that amniotomy procedure is very effective to reduce the time duration of labour and maternal risk factors. Amniotomy method is also applied when internal monitoring of fetus is required.

The mechanism of action behind amniotomy is thought to be the release of prostaglandin E2 (PGE2) and rise of oxytocin level.Routine early amniotomy appears to be associated with both benefits and risks. It's typically used to accelerate labour and was originally thought to decrease caesarean section rates. Amniotomy is a frequent and low-cost method of inducing labor. The link between early amniotomy and severe maternal morbidity varied according to maternal factors, while early amniotomy was not linked to newborn morbidity.

The current study has been planned to examine the effect of amniotomy in terms of reducing the time duration of labour in primigravida at term gestation. The study results obtained from our local setting will be useful for expertise while selecting the mode of delivery. Evidence-based guidelines will help in practicing standardize care, reduce variability in practice, reduce maternal and neonatal mortality and improve overall outcomes for mothers and babies.

Objective: To compare mean duration of labor in amniotomy compared to spontaneous rupture of membrane in primigravida at term pregnancy.

Operational definitions

Duration of labour: Time (hours) during active labour encompassing 1st and 2nd stage of labour will be noted using a stopwatch by nurse on duty. 1st stage will be labelled from cervical dilatation of 3-4 cm in active labor to full dilatation of cervix (≈ 10 cm) by vaginal examination conducted every 2 hours. The 2nd stage of labour will consist of a phase of active labour from full dilatation to delivery.

Body mass index (BMI): BMI will be calculated by formula- weight in kg/height in meter2. Weight will be measured on a weighing scale and height on stadiometer.

Hypothesis: Mean duration of labour is lower in amniotomy group compared to spontaneous rupture of membrane.

Material \& methods

Setting: Department of OBG, Recep Tayyip Erdoğan Hospital, Muzaffargarh

Study design: Randomized Controlled Trial

Duration: 6-months after approval of synopsis

Sample size10: Sample size is calculated through OpenEpi software using formula for mean difference. Where,

Labour duration in amniotomy group = 5.725±0.59 hours Power of the study = 80%

Labour duration in spontaneous membrane rupture = 7.150±0.48 hours

Confidence level = 95% Sample size = 60 (30 in each group)

Sampling technique: Non-probability consecutive sampling

Data collection procedure

Prior approval will be sought from the ethics review committee. A total of 60 women in labour room with active labour, fulfilling the inclusion criteria, will be enrolled with volountry participation after informed consent and confidentiality will be maintained. Baseline characteristics including age, body mass index and gestational age (by LMP method) will be recorded from all the participants. The participants will be randomly assigned to group A and B through lottery method using sealed opaque envelopes.

In group A, amniotomy at 3cm will be done using aseptic measurements with the help of

Kocher's forceps while in group B, membranes will be left intact. A partograph will be maintained in all patients throughout labor. Duration of each stage of labour will be monitored as per operational definition by the nurse not aware of treatment given. Fetal and maternal monitoring will be done half hourly till delivery of infant. Cesarean-section will be done in non-reactive CTG patients. In case of any of the adverse events related to intervention like placental abruption and cord prolapse [that is less likely as the subjects are primigravida patients in which head is mostly already engaged before onset of labour], and presence of meconium upon ARM that is not related to intervention individualized care will be provided like continuous electronic fetal monitoring and emergency caserean section will be kept in hand. If any adverse event occur related to intervention it will be reported to IRB within 24hours. All the patients will be kept under observation for 24 hours after delivery. All the data will be recorded on proforma

Data analysis The data will be analysed through SPSS version 23. The normality of numerical data will be assessed through the Shapiro-Wilk test. Age, BMI, gestational age and duration of labour will be presented as mean and standard deviation. Duration of labour will be compared between group A and group B through independent sample t-test and p-value ≤ 0.05 will be taken as significant. The data will be stratified on age groups, gestational age and BMI categories to determine the effect on duration of labour between group A and B. Post-stratification independent sample t-test will be applied and p-value ≤ 0.05 will be taken as significant.

02

Conditions studied

  • Labour

Keywords

  • Amniotomy in early labour
  • Effect of amniotimy in early labour in primigravida at term
03

In context

Lead sponsor

Indus Hospital and Health Network is the lead sponsor of 20 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 - 45 years
  • Primigravida, singleton fetus (on antenatal scan)
  • Full term - gestational age 37 - 41 weeks
  • Established labour (presence of regular uterine contractions - 3 per 10 minutes)

Exclusion criteria

Exclusion Criteria:

  • History of chronic hypertension, diabetes mellitus, gestational diabetes - on medical record
  • Rupture of the membrane (pooling of fluid in vaginal on speculum examination)
  • History of antepartum hemorrhage (history and medical record)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    Group A-Amniotimy group

    amniotomy performed at 3 cm cervical dilatation using aseptic technique

    Procedure: Amniotomy (intentional rupture of amniotic sac during labour)

  • No intervention
    Group B-Expectant group

    Membranes left intact untill spontaneous rupture of membranes occur

Interventions

  • ProcedureAmniotomy (intentional rupture of amniotic sac during labour)

    intentional rupture of amniotic sac during labour)

06

What researchers measure

Primary outcomes

  1. Mean duration of labour in amniotomy group and spontaneous rupture of membranes in primigravida at term pregnancy

    To compare the mean duration of labour in primigravida at term pregnancy undergoing amniotomy in early labour at 3-4 cm cervical dilatation versus expectant management until spontaneous rupture of membranes.

    Time frame: 6 months

07

Study locations

1 site
  • Indus hospital and health network
    Multan, Punjab Province 34200, Pakistan
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2025 to primary completion in Mar 2026, 5 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 6, 2026
First posted
Aug 13, 2026
StartActual
Oct 1, 2025
Primary completionActual
Mar 30, 2026
CompletionActual
Apr 28, 2026
Last update
Aug 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07764406
Lead sponsor
Indus Hospital and Health Network
Responsible party
Bushra Iqbal (Post graduate resident FCPS Gynae & Obs RTEH Muzaffagarh, Indus Hospital and Health Network) — Principal investigator
First posted
Aug 13, 2026
Start date
Oct 1, 2025
Primary completion
Mar 30, 2026
Completion
Apr 28, 2026
Last update
Aug 13, 2026

Study contacts

Bushra Iqbal, MBBS
principal investigator · Indus Hospital and Health Network

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion